These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34227923)

  • 1. Empirical and theoretical approaches for the prediction of human hepatic clearance using chimeric mice with humanised liver: the use of physiologically based scaling, a novel solution for potential overprediction due to coexisting mouse metabolism.
    Matsumoto S; Kamimura H; Nishiwaki M; Cho N; Kato K; Yamamoto T
    Xenobiotica; 2021 Sep; 51(9):983-994. PubMed ID: 34227923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting successful/unsuccessful extrapolation for in vivo total clearance of model compounds with a variety of hepatic intrinsic metabolism and protein bindings in humans from pharmacokinetic data using chimeric mice with humanised liver.
    Sawada T; Yamaura Y; Higuchi S; Imawaka H; Yamazaki H
    Xenobiotica; 2020 May; 50(5):526-535. PubMed ID: 31491346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver.
    Miyamoto M; Iwasaki S; Chisaki I; Nakagawa S; Amano N; Hirabayashi H
    Xenobiotica; 2017 Dec; 47(12):1052-1063. PubMed ID: 27892765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictability of human pharmacokinetics of drugs that undergo hepatic organic anion transporting polypeptide (OATP)-mediated transport using single-species allometric scaling in chimeric mice with humanized liver: integration with hepatic drug metabolism.
    Sanoh S; Naritomi Y; Kitamura S; Shinagawa A; Kakuni M; Tateno C; Ohta S
    Xenobiotica; 2020 Nov; 50(11):1370-1379. PubMed ID: 32401667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Prediction of OATP-Mediated Disposition and Biliary Clearance Using Human Liver Chimeric Mice.
    Miyake T; Tsutsui H; Hirabayashi M; Tachibana T
    J Pharmacol Exp Ther; 2023 Nov; 387(2):135-149. PubMed ID: 37142442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes.
    Ito K; Houston JB
    Pharm Res; 2004 May; 21(5):785-92. PubMed ID: 15180335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human pharmacokinetics for low-clearance compounds using pharmacokinetic data from chimeric mice with humanized livers.
    Yoshida K; Doi Y; Iwazaki N; Yasuhara H; Ikenaga Y; Shimizu H; Nakada T; Watanabe T; Tateno C; Sanoh S; Kotake Y
    Clin Transl Sci; 2022 Jan; 15(1):79-91. PubMed ID: 34080287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver.
    Sanoh S; Naritomi Y; Fujimoto M; Sato K; Kawamura A; Horiguchi A; Sugihara K; Kotake Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Xenobiotica; 2015; 45(7):605-14. PubMed ID: 25733030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics.
    Sanoh S; Ohta S
    Biopharm Drug Dispos; 2014 Mar; 35(2):71-86. PubMed ID: 24114658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches.
    Ito K; Houston JB
    Pharm Res; 2005 Jan; 22(1):103-12. PubMed ID: 15771236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of human pharmacokinetics of typical compounds by a physiologically based method using chimeric mice with humanized liver.
    Nakayama K; Ito S; Suzuki M; Takubo H; Yamazaki H; Nomura Y
    Xenobiotica; 2019 Apr; 49(4):404-414. PubMed ID: 29619871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with in Vitro-in Vivo Extrapolation and Allometric Scaling.
    Naritomi Y; Sanoh S; Ohta S
    Biol Pharm Bull; 2019; 42(3):327-336. PubMed ID: 30828063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery.
    Naritomi Y; Sanoh S; Ohta S
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):31-39. PubMed ID: 29183653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo hepatic clearance of lipophilic drugs predicted by in vitro uptake data into cryopreserved hepatocytes suspended in sera of rats, guinea pigs, monkeys and humans.
    Koyanagi T; Yano K; Kim S; Murayama N; Yamazaki H; Tamai I
    Xenobiotica; 2019 Aug; 49(8):887-894. PubMed ID: 30124359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Hepatic Clearance of Stereoselective Metabolism of Carvedilol in Liver Microsomes and Hepatocytes of Sprague-Dawley and Cytochrome P450 2D-Deficient Dark Agouti Rats.
    Iwaki M; Niwa T; Tanaka H; Kawase A; Komura H
    J Pharm Pharm Sci; 2019; 22(1):72-84. PubMed ID: 30678750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
    Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method.
    Shibata Y; Takahashi H; Chiba M; Ishii Y
    Drug Metab Dispos; 2002 Aug; 30(8):892-6. PubMed ID: 12124306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
    Riley RJ; McGinnity DF; Austin RP
    Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.